John F. Kelly, PhD, of the Recovery Research Institute and Department of Psychiatry at Mass General Brigham, is the lead ...

John F. Kelly, PhD , of the Recovery Research Institute and Department of Psychiatry at Mass General Brigham, is the lead author of a paper ...

Interleukin-23 inhibitors, prior treatment history, and Psoriasis Area and Severity Index scores may be predictive of time to disease relapse among patients with psoriasis who achieved clinical ...

Alcohol use disorder (AUD) is one of the leading causes of preventable death in the United States and worldwide, and leads to substantial disease and medical complications. While treatments are ...

But smokers who quit with the help of e-cigarettes are much more likely to continue using vapes. The post Study claims ...

Over one-third of MS patients do not fully recover post-relapse, with severity as the strongest predictor of incomplete recovery. Relapse-associated worsening (RAW) is crucial in understanding ...

In patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis treated with rituximab, risk factors for relapse differed by treatment phase; musculoskeletal involvement was ...

Relapse prevention is why most people seek treatment, and with opioid use disorders (OUDs), there’s about a 90 percent relapse rate. This article explains why and how specific sayings from self-help ...